Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.07.11.499519

Spatial and temporal muscle synergies provide a dual characterization of low-dimensional and intermittent control of upper-limb movements

Abstract

Muscle synergy analysis is commonly used for investigating the neurophysiological mechanisms that the central nervous system employs to control muscle activations. In the last two decades, several models have been developed to decompose EMG signals into spatial, temporal or spatiotemporal synergies. However, the presence of different approaches complicates the comparison and interpretation of results. Spatial synergies represent invariant activation weights in muscle groups modulated with variant temporal coefficients, while temporal synergies are based on invariant temporal profiles that coordinate variant muscle weights. While non-negative matrix factorization (NMF) allows to extract both spatial and temporal synergies, temporal synergies and the comparison between the two approaches have been barely investigated and so far no study targeted a large set of multi-joint upper limb movements. Here we present several analyses that highlight the duality of spatial and temporal synergies as a characterization of low-dimensional and intermittent motor coordination in the upper limb, allowing high flexibility and dexterity. First, spatial and temporal synergies were extracted from two datasets representing a comprehensive mapping of proximal (REACH PLUS) and distal (NINAPRO) upper limb movements, focusing on their differences in reconstruction accuracy and inter-individual variability. For both models, we extracted synergies achieving a given level of the goodness of reconstruction (R2), and we compared the similarity of the invariant components across participants. The two models provide a compact characterization of motor coordination at spatial or temporal level, respectively. However, a lower number of temporal synergies are needed to achieve the same R2 with a higher inter-subject similarity. Spatial and temporal synergies may thus capture different levels of motor control. Second, we showed the existence of both spatial and temporal structure in the EMG data, extracting spatial and temporal synergies from a surrogate dataset in which the phases were shuffled preserving the same frequency content of the original data. Last, a detailed characterization of the structure of the temporal synergies suggested that they can be related to an intermittent control of the movement. These results may be useful to improve muscle synergy analysis in several fields such as rehabilitation, prosthesis control and motor control studies.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Brambilla, C., Atzori, M., Müller, H., d'Avella, A., Scano, A.. 2022-07-12. Spatial and temporal muscle synergies provide a dual characterization of low-dimensional and intermittent control of upper-limb movements. https://doi.org/10.1101/2022.07.11.499519

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗